查找临床试验
已按「年龄相关性黄斑变性」检索，对应国际通用词 age-related macular degeneration
共找到 157 项正在招募的试验（在欧美日韩等发达国家设有中心）
数据更新于 00:25，每 5 分钟自动同步Development and Evaluation of Functional Visual Field and Navigation Endpoints in Moderate to Profound Inherited Retinal Disease (DEFINE-IRD)
United States
年龄 18 Years – 不限
Ray Therapeutics, Inc.
Progression Suppression and Retinal Regression in VEGF-resistant AMD
Japan
年龄 18 Years – 85 Years
PharmaBio Corporation
High Resolution Imaging OCT Study
Italy
年龄 18 Years – 不限
Heidelberg Engineering GmbH
Phase 1/2 Open-Label Dose-Escalation Study to Evaluate Safety of a Single Intravitreal Injection of RTx-021 in Patients With Stargardt Disease
United States
年龄 16 Years – 不限
Ray Therapeutics, Inc.
Safety of BBC1501 Intravitreal Injection in Patients With Neovascular Age-Related Macular Degeneration (nAMD)
Australia
年龄 50 Years – 不限
Benobio Co., Ltd.
Feasibility and Safety of MB-102 in Ocular Angiography as Compared to Fluorescein Sodium
United States
年龄 18 Years – 不限
MediBeacon
A Study About the Safety of a Single ASP2020 Eye Injection and if it Helps People With Vision Loss From Stargardt-type Eye Conditions
United States
年龄 6 Years – 不限
Astellas Institute for Regenerative Medicine
A Long-term Follow-up Study to Evaluate SKG0106 in the Treatment of Patients With nAMD
United States、China
年龄 50 Years – 不限
Skyline Therapeutics
Autologous Transplantation of Induced Pluripotent Stem Cell-Derived Retinal Pigment Epithelium for Geographic Atrophy Associated With Age-Related Macular Degeneration
United States
年龄 55 Years – 95 Years
National Eye Institute (NEI)
Treatment of Neovascular AMD: Artificial Intelligence in Real-world Setting
Austria
年龄 50 Years – 100 Years
Medical University of Vienna
Ethical Issues of Using Gene Therapy in the Treatment of AMD
France
年龄 18 Years – 不限
Nantes University Hospital
Single Intravitreal (IVT) Injection of 4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular Degeneration
United States、Argentina、Australia、Bulgaria、France 等 12 国
年龄 50 Years – 不限
4D Molecular Therapeutics